Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Burkitt Lymphoma 20Leukemia, Biphenotypic, Acute 12Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Acute 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Osteosarcoma 4Leukemia 4Neoplasm Metastasis 3Myelodysplastic Syndromes 3Down Syndrome 3Rhabdoid Tumor 2Recurrence 2Myeloproliferative Disorders 2Lymphoma, Mantle-Cell 2Lymphoma 2Leukemia, Myeloid, Accelerated Phase 2Head and Neck Neoplasms 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Blast Crisis 2Urothelial Carcinoma of the Bladder 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Shwachman-Diamond Syndrome 1Sarcoma, Ewing 1Renal Pelvis and Ureter Urothelial Carcinoma 1Oropharyngeal Neoplasms 1Neoplasms 1Muscle Invasive Bladder Urothelial Carcinoma 1Multiple Myeloma 1

Interventions

Temozolomide 8Vincristine 6Cyclophosphamide 5X-Rays 4Specimen Handling 4Phantoms, Imaging 4Magnetic Resonance Spectroscopy 4Irinotecan 4cabozantinib 3Ifosfamide 3Etoposide 3Doxorubicin 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2liposomal doxorubicin 2ivosidenib 2irinotecan sucrosofate 2fludarabine 2Topotecan 2Radiation 2Nuclear Medicine Department, Hospital 2LY3023414 2Eflornithine 2Congresses as Topic 2trifluridine tipiracil drug combination 1talazoparib 1silmitasertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Methotrexate × 90 days × Clear all
NCT07321912 2026-05-26

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Milton S. Hershey Medical Center

Phase 2 Recruiting
406 enrolled
Sarcoma

Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡